Curis Reports Fourth Quarter and Year-End 2013 Financial Results

[GlobeNewswire] – LEXINGTON, Mass. — Curis, Inc. , an oncology-focused company developing novel, targeted drug candidates for the treatment of human cancers, today reported its financial results for the fourth quarter … more

View todays social media effects on CRIS

View the latest stocks trending across Twitter. Click to view dashboard

See who Curis is hiring next, click here to view